These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11489138)

  • 1. Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as 'cotton wool' plaques.
    Mann DM; Takeuchi A; Sato S; Cairns NJ; Lantos PL; Rossor MN; Haltia M; Kalimo H; Iwatsubo T
    Neuropathol Appl Neurobiol; 2001 Jun; 27(3):189-96. PubMed ID: 11489138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43).
    Mann DM; Iwatsubo T; Cairns NJ; Lantos PL; Nochlin D; Sumi SM; Bird TD; Poorkaj P; Hardy J; Hutton M; Prihar G; Crook R; Rossor MN; Haltia M
    Ann Neurol; 1996 Aug; 40(2):149-56. PubMed ID: 8773595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
    Ishii K; Lippa C; Tomiyama T; Miyatake F; Ozawa K; Tamaoka A; Hasegawa T; Fraser PE; Shoji S; Nee LE; Pollen DA; St George-Hyslop PH; Ii K; Ohtake T; Kalaria RN; Rossor MN; Lantos PL; Cairns NJ; Farrer LA; Mori H
    Neurobiol Aging; 2001; 22(3):367-76. PubMed ID: 11378241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.
    Mann DM; Pickering-Brown SM; Takeuchi A; Iwatsubo T;
    Am J Pathol; 2001 Jun; 158(6):2165-75. PubMed ID: 11395394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein markers for Alzheimer disease in the frontal cortex and cerebellum.
    Verdile G; Gnjec A; Miklossy J; Fonte J; Veurink G; Bates K; Kakulas B; Mehta PD; Milward EA; Tan N; Lareu R; Lim D; Dharmarajan A; Martins RN
    Neurology; 2004 Oct; 63(8):1385-92. PubMed ID: 15505153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques.
    Shepherd CE; Gregory GC; Vickers JC; Brooks WS; Kwok JB; Schofield PR; Kril JJ; Halliday GM
    Neurobiol Dis; 2004 Feb; 15(1):115-9. PubMed ID: 14751776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.
    Mann DM; Iwatsubo T; Pickering-Brown SM; Owen F; Saido TC; Perry RH
    Neurosci Lett; 1997 Jan; 221(2-3):81-4. PubMed ID: 9121705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
    Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
    Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid (Abeta) deposition in chromosome 1-linked Alzheimer's disease: the Volga German families.
    Mann DM; Iwatsubo T; Nochlin D; Sumi SM; Levy-Lahad E; Bird TD
    Ann Neurol; 1997 Jan; 41(1):52-7. PubMed ID: 9005865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques.
    Steiner H; Revesz T; Neumann M; Romig H; Grim MG; Pesold B; Kretzschmar HA; Hardy J; Holton JL; Baumeister R; Houlden H; Haass C
    J Biol Chem; 2001 Mar; 276(10):7233-9. PubMed ID: 11084029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype.
    Verkkoniemi A; Kalimo H; Paetau A; Somer M; Iwatsubo T; Hardy J; Haltia M
    J Neuropathol Exp Neurol; 2001 May; 60(5):483-92. PubMed ID: 11379823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.
    McNamara MJ; Gomez-Isla T; Hyman BT
    Arch Neurol; 1998 Jul; 55(7):1001-4. PubMed ID: 9678319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy.
    Kwok JB; Halliday GM; Brooks WS; Dolios G; Laudon H; Murayama O; Hallupp M; Badenhop RF; Vickers J; Wang R; Naslund J; Takashima A; Gandy SE; Schofield PR
    J Biol Chem; 2003 Feb; 278(9):6748-54. PubMed ID: 12493737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Namba M; Hayashi Y; Nishinaka T; Namba R; Nakashima H; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2003 Oct; 106(4):348-56. PubMed ID: 12883830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions.
    Brooks WS; Kwok JB; Kril JJ; Broe GA; Blumbergs PC; Tannenberg AE; Lamont PJ; Hedges P; Schofield PR
    Brain; 2003 Apr; 126(Pt 4):783-91. PubMed ID: 12615638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy.
    Yasuda M; Maeda S; Kawamata T; Tamaoka A; Yamamoto Y; Kuroda S; Maeda K; Tanaka C
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):220-3. PubMed ID: 10644793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased A beta 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene.
    Ishii K; Ii K; Hasegawa T; Shoji S; Doi A; Mori H
    Neurosci Lett; 1997 May; 228(1):17-20. PubMed ID: 9197277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.